Tools
Back to Results

Debra D. Poutsiaka, MD, PhD


Overview

Programs + Specialties
Research Interests Bacterial infections in immunocompromised hosts with a focus on the prevention of infections in bone marrow transplant patients, gastrointestinal microbiota and its relationship to systemic inflammatory syndromes
Training + Education Boston University School of Medicine; Beth Israel Deaconess Medical Center; Tufts Medical Center
Board Certifications Infectious Disease, Internal Medicine
NPI # 1518982701
Gender Female

Locations + Directions

Tufts Medical Center
Biewend Building, 3rd Floor
800 Washington St.
Box 238
Boston, MA 02111
Fax #: 617-636-1580
Phone #: 617-636-7010

Honors + Awards

2012, "Top Doctor," U.S. News & World Report
2008, Infectious Disease Fellows' Clinical Care and Teaching Award
2000, Medical Housestaff Teaching Award, New England Medical Center
1999, 2001- 2003 ,Recognition by Tufts University School of Medicine Students for Excellence in Teaching in the Medicine Clerkship
1999, Oliver Smith Awards for Clinical Excellence, New England Medical Center

Publications + National Presentations

1. Poutsiaka DD, Munson D, Price LL, Chan GW, Snydman DR. Blood stream infection (BSI) and acute graft versus host diesase (GVHD) after hematopoietic stem cell transplantation (HSCT) are associated. Bone Marrow Transplantation, 2011; 46: 300-307.

2. Poutsiaka DD, Davidson LE, Kahn KL, Bates DW, Snydman DR, Hibberd PL. Risk factors for death after sepsis in patients immunosuppressed before onset of sepsis. Scand J Infect Dis, 2009; 41: 469-479.

3. Poutsiaka DD, Skiffington S, Miller KB, Hadley S, Snydman DR. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J Infection 2007; 54:567-571.

4. Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplantation 2007; 40:63-70.

5. Munoz-Price, LS, Slifkin M, Ruthazer R, Poutsiaka DD, Hadley S, Freeman R, Rohrer R, Angelis M, Cooper J, Fairchild R, Barefoot L, Bloom J, Fitzmaurice S, Snydman DR. The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients. Clin Infect Dis 2004; 39:1293-1299

6. Slifkin M, Tempesti P, Poutsiaka DD, Snydman DR. Late and atypical cytomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis 2001, 33:E62-68.

7. Golan Y, Poutsiaka DD, Tozzi S, Hadley S, Snydman DR. Daptomycin for line-related Leuconostoc bacteraemia. J Antimicrob Chemother 2001, 47:364-365.

8. Poutsiaka DD. Antimicrobial resistance in the chronically critically ill patient. Clinics in Chest Medicine 2001, 22:87-103

9. Munoz-Price, LS, Slifkin M, Ruthazer R, Poutsiaka DD, Hadley S, Freeman R, Rohrer R, Angelis M, Cooper J, Fairchild R, Barefoot L, Bloom J, Fitzmaurice S, Snydman DR. The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients. Clin Infect Dis 2004; 39:1293-1299

10. Poutsiaka DD, Skiffington S, Miller KB, Hadley S, Snydman DR. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J Infection 2007; 54:567-571.